Colorectal

#100177 NCT01183780
Title: A Randomized, Double-Blind, Multicenter Phase 3 Study of Irinotecan, Folinic Acid, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab or Placebo in Patients With Metastatic Colorectal Carcinoma Progressive During or Following First-Line Combination Therapy With Bevacizumab, Oxaliplatin, and a Fluoropyrimidine (14T-MC-JVBB)
Study Location: Temple Main Campus

#50358 NCT00098787
Title: Bevacizumab and Oxaliplatin combined with Irinotecan or Leucovorin and Fluorouracil in treating patients with Metastatic or Recurrent Colorectal Cancer
Study Location: Temple Main Campus

#81600 NCT00265850
Title: Cetuximab and or Bevacizumab combined with Combination Chemotherapy in treating patients wit Metastatic Colorectal Cancer
Study Location: Temple Main Campus

#90569 NCT00608361
Title: Dasatinib in Treating Patients with Metastatic or Unresctable Solid Tumor or Lymphoma
Study Location: Temple Main Campus

---

Print

Share

eMail

Text Size

A

A

A